Valuation: Beijing Chunlizhengda Medical Instruments Co., Ltd.

Capitalization 7.48B 8.47B 1.08B 914M 834M 796M 1.48B 98.22B 1.53B 9.69B 3.85B 47.32B 4.07B 3.98B 165B P/E ratio 2025 *
21.1x
P/E ratio 2026 * 16.8x
Enterprise value 7.48B 8.47B 1.08B 914M 834M 796M 1.48B 98.22B 1.53B 9.69B 3.85B 47.32B 4.07B 3.98B 165B EV / Sales 2025 *
7.05x
EV / Sales 2026 * 5.89x
Free-Float
38.01%
Yield 2025 *
1.34%
Yield 2026 * 1.68%
01-30 Beijing Chunlizhengda Expects Up to 130% Higher 2025 Profit MT
01-30 Beijing Chunlizhengda Medical Instruments sees FY net profit attributable RMB245 to RMB288 million RE
01-29 Beijing Chunlizhengda Medical Instruments Co., Ltd. Provides Earnings Guidance for the Period of 1 January 2025 to 31 December 2025 CI
11-20 Beijing Chunlizhengda Medical Instruments Co., Ltd. Approves Dividend for the Third Quarter Ended 30 September 2025 CI
31/10/25 Beijing Chunlizhengda Medical Returns to Profitability in Q3 MT
31/10/25 Beijing Chunlizhengda Medical Instruments Co., Ltd. Proposes Dividend for the Third Quarter Ended 30 September 2025, Payable on 19 January 2026 CI
31/10/25 Beijing Chunlizhengda Medical Instruments Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
01/09/25 Beijing Chunlizhengda Medical Instruments' H1 Profit Rises; Shares Surge 9% MT
29/08/25 Beijing Chunlizhengda Medical Instruments Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
08/08/25 Chunlizhengda Medical Instruments to Jointly Invest in Healthcare Partnership Fund MT
27/06/25 Beijing Chunlizhengda Medical Instruments Co., Ltd. Approves Final Ordinary Dividend for the Year Ended 31 December 2024, Payable on 31 July 2025 CI
13/06/25 Tranche Update on Beijing Chunlizhengda Medical Instruments Co., Ltd.'s Equity Buyback Plan announced on June 18, 2024. CI
12/06/25 Beijing Chunlizhengda Medical Instruments Co., Ltd. 's Equity Buyback announced on June 18, 2024 has closed with 1,376,851 shares, representing 0.36% for CNY 20.01 million. CI
1 day+3.86%
1 week+0.94%
Current month-1.34%
1 month-7.96%
3 months-28.46%
6 months-18.41%
Current year-5.79%
1 week 13.47
Extreme 13.47
14.26
1 month 13.47
Extreme 13.47
17.07
Current year 13.47
Extreme 13.47
17.07
1 year 8.25
Extreme 8.25
20.82
3 years 6.18
Extreme 6.18
22.55
5 years 6.18
Extreme 6.18
34.95
10 years 2.26
Extreme 2.256
63
Manager TitleAgeSince
Chief Executive Officer 41 28/03/2022
Corporate Officer/Principal 54 16/04/2014
Chief Executive Officer 56 01/09/2010
Director TitleAgeSince
Director/Board Member 71 17/09/2010
Director/Board Member 64 25/08/2020
Chairman 56 01/09/2010
Change 5d. change 1-year change 3-years change Capi.($)
+3.86%+0.94%+64.71%-29.79% 1.08B
+0.59%+0.95%-5.13%+38.40% 140B
+1.83%+1.01%+28.15%+13.86% 15.12B
-1.54%-4.62%-16.75%-65.73% 6.41B
-2.10%-5.97%-25.69%+111.58% 6.13B
+0.04%-4.51%+37.94%+28.16% 2.82B
-0.75%-5.22%-5.38%-23.53% 2.01B
-12.55%-9.07%-68.10%-77.33% 1.7B
-0.62%-1.06%-8.40%-32.17% 1.72B
Average -1.25%-3.04%+0.15%-4.06% 19.67B
Weighted average by Cap. +0.38%+0.33%-2.95%+31.98%

Financials

2025 *2026 *
Net sales 1.06B 1.2B 154M 130M 118M 113M 210M 13.94B 217M 1.37B 547M 6.71B 577M 565M 23.45B 1.27B 1.44B 184M 155M 142M 135M 251M 16.68B 260M 1.64B 654M 8.03B 690M 676M 28.06B
Net income 219M 248M 31.69M 26.71M 24.38M 23.27M 43.21M 2.87B 44.68M 283M 113M 1.38B 119M 116M 4.83B 271M 307M 39.33M 33.14M 30.25M 28.87M 53.61M 3.56B 55.45M 351M 140M 1.72B 147M 144M 6B
Net Debt - -
Logo Beijing Chunlizhengda Medical Instruments Co., Ltd.
Beijing Chunlizhengda Medical Instruments Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of implantable orthopedic medical devices. The Company's main products are joint prosthesis products and spine implant products. The joint prosthesis products cover four human joints: hip, knee, shoulder and elbow. The spine implant products are a full range of product combinations of spinal internal fixation systems. The Company's products are exported to Asia, South America, Africa, Oceania, Europe and other countries and regions.
Employees
1,237
Date Price Change Volume
13/02/26 14.00 $ +3.86% 541,750
12/02/26 13.48 $ -3.51% 749,500
11/02/26 13.97 $ -0.21% 560,000
10/02/26 14.00 $ +0.50% 774,250
09/02/26 13.93 $ +0.43% 543,500
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
11.90CNY
Average target price
16.11CNY
Spread / Average Target
+35.40%

Annual profits - Rate of surprise